Получена: 24.03.2024/ Принята: 08.04.202/Опубликована online: 29.04.2024
УДК 331:616-051
DOI: 10.53511/pharmkaz.2024.28.79.027
М.А. Рамазанова1, Б.С.Турдалиева2, Б.С.Байсеркин2, Г.Е.Аимбетова3,
Ф.А. Багиярова 3, А.Е.Турсынбекова 3, Л.Ю.Ганина 2,Р.И.Кульманбетов3
1Казахстанский медицинский университет «ВШОЗ», Алматы, Казахстан
2Казахский научный центр дерматологии и инфекционных заболеваний, Алматы, Казахстан
3НАО Казахский национальный медицинский университет им. С.Д.Асфендиярова, Алматы, Казахстан
ВИЧ ИНФЕКЦИЯ И НОВЫЕ ПСИХОАКТИВНЫЕ ВЕЩЕСТВА:
ОБЩИЕ ЭПИДЕМИОЛОГИЧЕСКИЕ ТЕНДЕНЦИИ В МИРЕ И КАЗАХСТАНЕ (обзор)
Резюме.
Актуальность: В данной статье рассматриваются общие эпидемиологические данные ВИЧ-инфекции среди
Растет беспокойство по поводу быстро растущего рынка новых психоактивных веществ в мире. Выявленные
особенности поведения потребителеи новых психоактивных веществ говорят о наличии у них актуальных рисков
инфицирования ВИЧ как инъекционного, так и сексуального плана.
Цель: проведение анализа общих эпидемиологических тенденции ВИЧ-инфекции среди потребителей новых
психоактивных веществ в мире и Казахстане.
Материалы и методы исследования. Был проведен поиск и анализ научных публикаций в базах данных
электронной библиотеки e-Library, Pubmed, Web of Science, Scopus, MEDLINE с использованием комбинаций
медицинских тематических заголовков и ключевых слов.
Результаты: По итогам проведенного литературного обзора результаты исследования является актуальной
проблемой в здравоохранении. Психоактивные вещества являются потенциальнымы факторами риска ВИЧинфекции среди молодежи. Хроническое употребление может вызвать не только когнитивные нарушения, но и
другие психические расстройства, что вызывает обеспокоенность по поводу влияния на удержание и
приверженность лечению ВИЧ.
Ключевые слова: ВИЧ инфекция, новые психоактивные вещества, распространенность, профилактика.
СПИСОК ЛИТЕРАТУРЫ
1 В.В. Мрыхин, А.В. Анцыборов Дизайнерские наркотики: краткая история, попытка систематизации на примере
«спайсов» и «солей» (обзор)
2 https://www.unodc.org/LSS/Page/NPS
3 Ottersen O, Dasgupta J, Blouin C, Buss P, Chongsuvivatwong V, Frenk J, et al. The political origins of health inequity:
prospects for change. Lancet. 2014;383(9917):630–67.
4 Piot P, Abdool Karim SS, Hecht R, Legido-Quigley H, Buse K, Stover J, et al. Defeating AIDS – advancing global health. Lancet. 2015;386(9989):171–218.
5 UNAIDS. The gap report. Geneva: Joint United Nations Programme on HIV/AIDS; 2014. Available from:
http://files.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2014/UNAIDS_Gap_report_en.pdf
6 UNODC. World Drug Report: 2014. Vienna; 2014. Available from: https://
www.unodc.org/documents/wdr2014/World_Drug_Report_2014_web.pdf
7 Oesterle S, Hill KG, Hawkins JD, Guo J, Catalano RF, Abbott RD. Adolescent heavy episodic drinking trajectories and health
in young adulthood. J Stud Alcohol. 2007;65(2):204–12.
8 WHO, Global status report on alcohol and health. Geneva; 2014. Available from:
http://apps.who.int/iris/bitstream/10665/112736/1/9789240692763_eng.pdf)
9 Amy Peacock, Janni Leung, Sarah Larney, Samantha Colledge, Matthew Hickman, Jürgen Rehm, Gary A. Giovino, Robert
West, Wayne Hall, P Paul Griffiths, Robert Ali, Linda Gowing, John Marsden, Alize J. Ferrari, Jason Grebely, Michael
Farrell, Louisa Degenhardtaul GriffithsGlobal statistics on alcohol, tobacco and illicit drug use: 2017 status report
10 Управление ООН по наркотикам и преступности (УНП ООН) . Всемирный доклад о наркотиках, 2017 год . Вена :
УНП ООН; 2017
11 Karila L., Lafaye G., Scocard A., Cottencin O., Benyamina A. MDPV and α-PVP use in humans: The twisted sisters //
Neuropharmacology. – 2018. – Vol. 134. – Part A. – P. 65–72. – doi: 10.1016/j. neuropharm.2017.10.007,
12 Measham F., Moore K., Newcombe R., Welch Z. Tweaking, bombing, dabbing and stockpiling : The emergence of
mephedrone and the perversity of prohibition // Drugs and Alcohol Today. – 2010. – Vol.10. – N1. – P. 14–21. – doi:
10.5042/daat.2010.0123,
13 Tracy D.K., Wood D.M., Baumeister D. Novel psychoactive substances: Types, mechanisms of action, and effects // BMJ. –
2017. – Vol. 356. – N6848. – P. 1–7. – doi: 10.1136/bmj.i6848.
14 Togari T, Inoue Y, Takaku Y, Abe S, Hosokawa R, Itagaki T, Yoshizawa S, Oki S, Katakura N, Yamauchi A, Wakabayashi C,
Yajima T. Recreational drug use and related social factors among HIV-positive men in Japan. AIDS Care. 2016 Jul;28(7):932-
40. doi: 10.1080/09540121.2016.1140888. Epub 2016 Feb 17. PMID: 26887351.
15 Korf D., Benschop A., Werse B., Kamphausen G., Felvinczi K., Dabrowska K., Hernriques S., Nabben T., Wieczorek L.,
Bujalski M., Kalo Z., Hearne E., Van Hout M. How and where to find NPS users: a comparison of methods in a cross-national
survey among three groups of current users of new psychoactive substances in Europe // Int J Ment Health Addiction. – 2019.
– doi: 10.1007/ s11469-019-0052-8.
16 Meylakhs P., Friedman S.R., Meylakhs A., Mateu-Gelabert P., Ompad D.C., Alieva A. et al. A new generation of drug users in
St. Petersburg, Russia? HIV, HCV, and overdose risks in a mixedmethods pilot study of young hard drug users // AIDS Behav.
– 2019. – Vol. 23. – N12. – P. 3350– 3365. – doi: 10.1007/s10461-019-02489-6
17 Lifson AR, Workneh S, Shenie T, Ayana DA, Melaku Z, Bezabih L, Waktola HT, Dagne B, Hilk R, Winters KC, Slater L.
Frequent Use of Khat, an Amphetamine-Like Substance, as a Risk Factor for Poor Adherence and Lost to Follow-Up Among
Patients New to HIV Care in Ethiopia. AIDS Res Hum Retroviruses. 2017 Oct;33(10):995-998. doi: 10.1089/AID.2016.0274.
Epub 2017 May 30. PMID: 28462628; PMCID: PMC5650715.
18 Garin N, Zurita B, Velasco C, Feliu A, Gutierrez M, Masip M, Mangues MA. Prevalence and clinical impact of recreational
drug consumption in people living with HIV on treatment: a cross-sectional study. BMJ Open. 2017 Jan 18;7(1):e014105. doi:
10.1136/bmjopen-2016-014105. PMID: 28100565; PMCID: PMC5253545
19 Michel L, Hammett T, Laureillard D, Nagot N, Des Jarlais D; DRIVE Study Team. Increased Methamphetamine Use among
Persons Who Inject Drugs in Hai Phong, Vietnam, and the Association with Injection and Sexual Risk Behaviors. J
Psychoactive Drugs. 2018 Nov-Dec;50(5):382-389. doi: 10.1080/02791072.2018.1508790. Epub 2018 Sep 5. PMID:
30183558; PMCID: PMC6379246
20 Giraudon I, Schmidt AJ, Mohammed H. Surveillance of sexualised drug use – the challenges and the opportunities. Int J
Drug Policy. 2018 May;55:149-154. doi: 10.1016/j.drugpo.2018.03.017. Epub 2018 Mar 27. PMID: 29598967
DOI: 10.1016/j.drugpo.2018.03.017.
21 Curtis TJ, Rodger AJ, Burns F, Nardone A, Copas A, Wayal S. Patterns of sexualised recreational drug use and its
association with risk behaviours and sexual health outcomes in men who have sex with men in London, UK: a comparison of
cross-sectional studies conducted in 2013 and 2016. Sex Transm Infect. 2020 May;96(3):197-203. doi: 10.1136/sextrans2019-054139. Epub 2019 Nov 19. PMID: 31744928; PMCID: PMC7167300
22 Edmundson C, Heinsbroek E, Glass R, Hope V, Mohammed H, White M, Desai M. Sexualised drug use in the United
Kingdom (UK): A review of the literature. Int J Drug Policy. 2018 May;55:131-148. doi: 10.1016/j.drugpo.2018.02.002. Epub
2018 Apr 4. PMID: 29625796.
23 White M, Desai M. Sexualised drug use in the United Kingdom (UK): A review of the literature. Int J Drug Policy. 2018
May;55:131-148. doi: 10.1016/j.drugpo.2018.02.002. Epub 2018 Apr 4. PMID: 29625796.
24 Hibbert MP, Brett CE, Porcellato LA, Hope VD. Psychosocial and sexual characteristics associated with sexualised drug use
and chemsex among men who have sex with men (MSM) in the UK. Sex Transm Infect. 2019 Aug;95(5):342-350. doi:
10.1136/sextrans-2018-053933. Epub 2019 Apr 12. PMID: 30979782
25 Anne Batisse, Hélène Peyrière, Céline Eiden, Marie-Anne Courné, Samira Djezzar Usage de psychostimulants dans un
contexte sexuel : analyse des cas rapportés au Réseau français des centres d’addictovigilance. Évaluation des risques liés à la
192
pratique du SLAMUse of psychostimulants in a sexual context: Analysis of cases reported to the French network of
Addictovigilance Centers. https://doi.org/10.1016/j.therap.2016.04.003
26 Fuster-Ruizde, Apodaca M.J, Castro-Granell V, Garin N, Laguía A, Jaén Á, Iniesta C, Cenoz S, Galindo MJ. Prevalence and
patterns of illicit drug use in people living with HIV in Spain: A cross-sectional study. PLoS One. 2019 Jun 17;14(6):e0211252.
doi: 10.1371/journal.pone.0211252. PMID: 31206550; PMCID: PMC6576760
27 Li L, Zhou C, Li XY, Wang XD, Wu ZY.Zhonghua Liu Xing Bing Xue Za Zhi. Psychoactive substances use in men who have sex
with men in China: an internet based survey. 2021 Apr 10;42(4):690-694. doi: 10.3760/cma.j.cn112338-20200615-
00842.PMID: 34814452
28 Ibigbami O.I, Oginni O.A, Bradley C, Lusher J, Sam-Agudu NA, Folayan MO. A cross-sectional study on resilience, anxiety,
depression, and psychoactive substance use among heterosexual and sexual minority adolescents in Nigeria. BMC Public
Health. 2023 Sep 9;23(1):1759. doi: 10.1186/s12889-023-16660-1. PMID: 37689625; PMCID: PMC10493016.
29 Folayan M.O, Arowolo O, Mapayi B, Chukwumah NM, Alade MA, Yassin RH, El Tantawi M. Associations between mental
health problems and risky oral and sexual behaviour in adolescents in a sub-urban community in Southwest Nigeria. BMC
Oral Health. 2021 Aug 16;21(1):401. doi: 10.1186/s12903-021-01768-w. PMID: 34399740; PMCID: PMC8365974
30 Folayan MO, Ibigbami O, El Tantawi M, Aly NM, Zuñiga RAA, Abeldaño GF, Ara E, Ellakany P, Gaffar B, Al-Khanati NM,
Idigbe I, Ishabiyi AO, Khan AT, Khalid Z, Lawal FB, Lusher J, Nzimande NP, Popoola BO, Quadri MFA, Roque M, Okeibunor JC,
Brown B, Nguyen AL. Associations between mental health challenges, sexual activity, alcohol consumption, use of other
psychoactive substances and use of COVID-19 preventive measures during the first wave of the COVID-19 pandemic by adults
in Nigeria. BMC Public Health. 2023 Aug 9;23(1):1506. doi: 10.1186/s12889-023-16440-x. PMID: 37559049; PMCID:
PMC10410824
31 Folayan M.O, Abeldaño Zuniga RA, Abeldaño GF, Quadri MFA, Jafer M, Yousaf MA, Ellakany P, Nzimande N, Ara E, AlKhanati NM, Khalid Z, Lawal F, Roque M, Lusher J, Popoola BO, Khan AT, Ayanore MA, Gaffar B, Virtanen JI, Aly NM, Okeibunor
JC, El Tantawi M, Nguyen AL. Is self-reported depression, HIV status, COVID-19 health risk profile and SARS-CoV-2 exposure
associated with difficulty in adhering to COVID-19 prevention measures among residents in West Africa? BMC Public Health.
2022 Nov 10;22(1):2057. doi: 10.1186/s12889-022-14429-6. PMID: 36357851; PMCID: PMC9648438
32 Abubakar AU, Abubakar AA, Sufiyan MB, Balogun MS, Awosan KJ, Raji IA, Usman AB, Abdullahi AM, Njidda AM, Bala HA,
Kaoje AU, Nguku PM, Shehu AU. Knowledge of health effects and determinants of psychoactive substance use among
secondary school students in Sokoto Metropolis, Nigeria. Pan Afr Med J. 2021 Oct 19;40:109. doi:
10.11604/pamj.2021.40.109.22000. PMID: 34887983; PMCID: PMC8627133.
33 Zarrouq B, Bendaou B, El Asri A, Achour S, Rammouz I, Aalouane R, Lyoussi B, Khelafa S, Bout A, Berhili N, Hlal H, Najdi A,
Nejjari C, El Rhazi K. Psychoactive substances use and associated factors among middle and high school students in the North
Center of Morocco: a cross-sectional questionnaire survey. BMC Public Health. 2016 Jun 4;16:468. doi: 10.1186/s12889-016-
3143-5. PMID: 27262322; PMCID: PMC4893420.
34 Birhanu A.M, Bisetegn T.A, Woldeyohannes S.M. High prevalence of substance use and associated factors among high
school adolescents in Woreta Town, Northwest Ethiopia: multi-domain factor analysis. BMC Public Health. 2014 Nov
20;14:1186. doi: 10.1186/1471-2458-14-1186. PMID: 25410657; PMCID: PMC4289242
35 Seid L, Gintamo B, Mekuria ZN, Hassen HS, Gizaw Z. Substance use and associated factors among preparatory school
students in Kolfe-Keranyo sub-city of Addis Ababa, Ethiopia. Environ Health Prev Med. 2021 Nov 19;26(1):110. doi:
10.1186/s12199-021-01032-1. PMID: 34798804; PMCID: PMC8603476.
36 Hirpa S, Fogarty AW, Addissie A, Bauld L, Frese T, Unverzagt S, Kantelhardt EJ, Getachew S, Deressa W. Prevalence and
risk factors for tobacco, khat, and alcohol consumption among high school students in Ethiopia. BMC Public Health. 2023 Feb
2;23(1):226. doi: 10.1186/s12889-023-15088-x. PMID: 36732737; PMCID: PMC9893175.
37 Deressa W, Azazh A. Substance use and its predictors among undergraduate medical students of Addis Ababa University
in Ethiopia. BMC Public Health. 2011 Aug 22;11:660. doi: 10.1186/1471-2458-11-660. PMID: 21859483; PMCID:
PMC3170623.
38 Nevendorff L, Schroeder SE, Pedrana A, Bourne A, Stoové M. Prevalence of sexualized drug use and risk of HIV among
sexually active MSM in East and South Asian countries: systematic review and meta-analysis. J Int AIDS Soc. 2023
Jan;26(1):e26054. doi: 10.1002/jia2.26054. PMID: 36600479; PMCID: PMC9813405.
39 Karila L., Megarbane B., Cottencin O., Lejoyeux M. Synthetic cathinones: a new public health problem // J. Curr
Neuropharmacol. – 2015. – Vol. 13. – N1. – P. 12–20. – doi: 10.2174/1570159X 13666141210224137.
40 Pufall E.L., Kall M., Shahmanesh M., Nardone A., Gilson R., Delpech V., Ward H. et al. Sexualized drug use (’chemsex’) and
high-risk sexual behaviours in HIV-positive men who have sex with men // HIV Medicine. – 2018. – Vol. 19. – N4. – P. 261–
270. – doi: 10.1111/hiv.12574.
41 Sewell J., Cambiano V., Speakman A., Lampe F.C., Phillips A., Stuart D, Gilson R., Asboe D., Nwokolo N., Clarke A., Rodger A.J.
Changes in chemsex and sexual behaviour over time, among a cohort of MSM in London and Brighton: Findings from the
AURAH2 study // Int J Drug Policy. – 2019. – Vol. 68. – P. 54–61. – doi: 10.1016/j.drugpo.2019.03.021.
42 Stanciu C., Penders T., Gnanasegaram S., Pirapakaran E., Padda J., Padda J. The behavioral profile of methylenedioxypyrovalerone (MDPV) and α–pyrrolidinopentiophenone (PVP) – A Systematic Review // Curr Drug Abuse
Rev. – 2017. – Vol. 10. – N999. – P. 1. – doi: 10.2174/1874473710666 170321122226.
193
43 Winstock A.R., Mitcheson L.R., Deluca P., Davey Z., Corazza O., Schifano F. Mephedrone, new kid for the chop? // Addiction.
– 2011. – Vol. 106. – N1. – P. 154–161. – doi: 10.1111/j.1360- 0443.2010.03130.x
44 Ezema G.C, Aniwada E.C, Onwasigwe C.N. Substance Use and Treatment Outcome among People Living With HIV
[PLWHIV] Accessing Care at CIDC 161 NAF Hospital, Makurdi, Nigeria: Implication for Intervention. West Afr J Med. 2022 Sep
16;39(9):973-981. PMID: 36128886
45 Hayashi K, Wakabayashi C, Ikushima Y, Tarui M. High prevalence of quasi-legal psychoactive substance use among male
patients in HIV care in Japan: a cross-sectional study. Subst Abuse Treat Prev Policy. 2017 Feb 23;12(1):11. doi:
10.1186/s13011-017-0097-2. PMID: 28231843; PMCID: PMC5324217
46 Starr A, Jordan-Sciutto KL, Mironets E.Viruses. Confound, Cause, or Cure: The Effect of Cannabinoids on HIV-Associated
Neurological Sequelae. 2021 Jun 26;13(7):1242. doi: 10.3390/v13071242.PMID: 34206839
47 Anthony A Olashore, Saeeda Paruk, Merrian Brooks, Bonginkosi Chiliza Psychoactive Substance Use Disorder in HIVInfected Adolescents in Botswana: A Comparison Between the Congenitally Infected and Behaviorally Infected Adolescents
PMID: 36875743 PMCID: PMC9974603 DOI: 10.1177/11782218231152818
48 Skochilov R, Aserova E, Lakhov A, Antonova D, Кulikova I, Shagina A, Heimer R Behavioral patterns of people who use
synthetic psychostimulants: Results of a qualitative study in St. Petersburg, Russia. Int J Drug Policy. 2022 Sep;107:103790.
doi: 10.1016/j.drugpo.2022.103790. Epub 2022 Jul 16.PMID: 35849936
49 Armoon B, Griffiths MD, Mohammadi R. The Global Distribution and Epidemiology of Psychoactive Substance Use and
Injection Drug Use Among Street-Involved Children and Youth: A Meta-Analysis. Subst Use Misuse. 2023;58(6):746-764. doi:
10.1080/10826084.2023.2181036. Epub 2023 Mar 16.PMID: 36924274
50 Farabee D, Prendergast M, Cartier J.J. Methamphetamine use and HIV risk among substance-abusing offenders in
California. Psychoactive Drugs. 2002 Jul-Sep;34(3):295-300. doi: 10.1080/02791072.2002.10399966.PMID: 12422940
51 Hayashi K, Wakabayashi C, Ikushima Y, Tarui M. Characterizing changes in drug use behaviour following supply shortages
of 5-MeO-DIPT, alkyl nitrites and new psychoactive substances among men living with HIV in Japan. Int J Drug Policy. 2023
Aug;118:104080. doi: 10.1016/j.drugpo.2023.104080. Epub 2023 Jun 10.PMID: 37307787
52 Ladak F, Socias E, Nolan S, Dong H, Kerr T, Wood E, Montaner J, Milloy M.J. Substance use patterns and HIV-1 RNA viral
load rebound among HIV-positive illicit drug users in a Canadian setting. Antivir Ther. 2019;24(1):19-25. doi:
10.3851/IMP3265.PMID: 30230474
53 Louisa Degenhardt and others, “Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the
WHO World Mental Health Surveys”, PLoS Medicine, vol. 5, No.
54 European Monitoring Centre for Drugs and Drug Addiction, High-risk drug use and new psychoactive substances //
EMCDDA Rapid Communication, Publications Office of the European Union – 2017. – URL:
https://www.emcdda.europa.eu/system/files/publications/4540/ TD0217575ENN.pdf. – (accessed 10.09.2020)
55 Еремин В.Ф., Гасич Е.Л., Сосинович С.В., Юровский П.Н. Расшифровка вспышки ВИЧ-инфекции среди лиц,
употребляющих инъекционные психотропные препараты, с использованием методов молекулярной эпидемиологии
// ВИЧ-инфекция и иммуносупрессии. 2016. Т. 8, No 4. С. 66–67
56 К.С. Алтынбеков, Н.А. Негай, А.А. Абетова «Методология и результаты национального исследования по
потреблению психоактивных веществ среди молодежи в Республике Казахстан», вестник КазНМУ, 2021 №4.
57 Постановление Правительства Республики Казахстан от 26 декабря 2019 года № 982 «Об утверждении
Государственной программы развития здравоохранения Республики Казахстан на 2020–2025 годы». Астана;
Информационно-правовая система нормативных правовых актов Республики Казахстан, 2019. Доступно на русском
языке по ссылке: https://adilet.zan.kz/rus/docs/P1900000982.
58 Заседание Совета по молодежной политике Республики Казахстан по вопросам борьбы с наркоманией
https://www.gov.kz/memleket/entities/ (дата обращения 23.08.2022)
